The BC-CfE’s Dr. Jeffrey Joy has joined an international team of researchers in the fight against COVID-19. Dr. Joy, a Senior Research Scientist specializing in evolutionary genetics, molecular epidemiology and bioinformatics at the BC-CfE, is also an Assistant Professor of Medicine at the University of British Columbia.
The result of a longstanding collaboration between SFU and the BC-CfE, new research from the laboratories of Drs. Mark Brockman and Zabrina Brumme was recently published in the respected scientific journalPLoS Pathogens.
The BC-CfE’s Executive Director & Physician-in-Chief Dr. Julio Montaner was honoured by Canada Post this week as part of their Medical Groundbreakers stamp series.
Earlier this year Providence Health Care announced Dr. Val Montessori as the new Head of its Division of Infectious Diseases in the Department of Medicine at St. Paul’s Hospital (SPH). We spoke with Dr. Montessori to find out what inspires and informs her work as she takes on this important new role.
The BC-CfE’s Nance Cunningham, an Experimental Medicine PhD student working in the EMBARC team (Epidemiological, Mathematical and Biostatistical analysis and Research Collaboration in HIV/AIDS) has been chosen as a UBC Public Scholar.The Public Scholars Initiative (PSI)supports creative, action-oriented research designed to address complex challenges and have meaningful public impact as part of a PhD thesis. The award will support Cunningham’s research partnerships with people affected by hepatitis C, and patient advocacy activists.
Globally, one in three women will experience some form of intimate partner violence in their lives. Some North American studies indicate this may be much more likely for women living with HIV. Despite improvements in HIV disease outcomes among women living with HIV in BC, multiple interacting inequities continue to disproportionately impact the health, wellbeing, and survival of women living with HIV.
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
